Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis-1 with Everolimus: A Phase II, Open-Label, Single-Arm Trial

John M. Slopis, Mary Kay Koenig, Cynthia Bell et al.|Drugs in R&D|2018

Cited by 26